Abstract: The present invention relates to an anti-angiogenic composition containing macrolactin compounds such as macrolactin A, 7-O-malonyl macrolactin A, and 7-O-succinyl macrolactin A as active ingredients. The macrolactin compounds according to the present invention strongly suppress angiogenesis in in vivo experiments and can be used as a pharmaceutical composition for preventing or treating diseases caused by angiogenesis.

Abstract: Provided are a method for removing and/or absorbing greenhouse gases using aquatic plant and/or algae having a greenhouse gas absorbing performance and resistance to toxic substances, a method for producing bioenergy using predators with high fatty acids, and a method for producing bioenergy including cultivating aquatic plant and/or algae having a greenhouse gas absorbing performance and resistance to toxic substances, while supplying a waste gas mixture to the aquatic plant and/or algae, (S2) cultivating predators having a capability to prey on the aquatic plant and/or algae while supplying the aquatic plant and/or algae to the predators, (S3) harvesting the predators, and (S4) converting the harvested predators into bioenergy.

Abstract: The present invention relates to an anti-angiogenic composition containing macrolactin compounds such as macrolactin A, 7-O-malonyl macrolactin A, and 7-O-succinyl macrolactin A as active ingredients. The macrolactin compounds according to the present invention strongly suppress angiogenesis in in vivo experiments and can be used as a pharmaceutical composition for preventing or treating diseases caused by angiogenesis.

Abstract: In a method of forming a pattern, a first mask layer and a first sacrificial layer may be sequentially formed on an object layer. The first sacrificial layer may be partially etched to form a first sacrificial layer pattern. A second sacrificial layer pattern may be formed on the first mask layer. The second sacrificial layer pattern may enclose a sidewall of the first sacrificial layer pattern. The first sacrificial layer pattern may then be removed. The first mask layer may be partially etched using the second sacrificial layer pattern as an etching mask to form a first mask layer pattern. The object layer may be partially etched using the first mask layer pattern as an etching mask.

Abstract: A baby formula maker including: a main body in which a water tub and a baby formula tub are installed; a heating portion installed in the main body and heating water contained in the water tub; a time controller controlling time at which the water is heated by the heating portion; a cooling portion including a radiator cooling the water heated by the heating portion and one or a plurality of Peltier cooling modules attached to the radiator so as to lower the temperature of the radiator; and a electric current controller controlling temperatures of the one or the plurality of Peltier cooling modules. The time required to make milk for nursing can be remarkably reduced, and if milk for nursing is needed, immediate nursing can be carried out, and speed and convenience can be provided to the user, and the baby formula maker is sanitary and compact and has a simple structure and thus can be economically manufactured on a mass scale.

Abstract: The present invention relates to an anti-inflammatory use of macrolactin compounds such as macrolactin A, 7-O-malonyl macrolactin A and 7-O-succinyl macrolactin A, which are produced from a novel Bacillus strain of Bacillus polyfermenticus KJS-2 (KCCM10769P). The macrolactin compounds provided by the present invention were confirmed to greatly suppress the expression and formation of inducible nitric oxide synthetase (iNOS) and cyclooxygenase-2 (COX-2) which are proteins related to the formation of inflammatory mediators, and to accordingly inhibit the formation of nitric oxide (NO) and of prostaglandin E2 (PGE2) which are the metabolites of the proteins. In addition, the macrolactin compounds provided by the present invention were confirmed to have excellent effects in inhibiting the formation of tumor necrosis factor-alpha (TNF-?), interleukin-1? (IL-1?), interleukin-6 (IL-6) and granulocyte macrophage colony-stimulating factor (GM-CSF), which are pro-inflammatory cytokines.

Abstract: The present invention relates to a composition for the treatment of gout, comprising an Angelica gigas Nakai extract which inhibits xanthine oxidase to reduce uric acid in the blood or urine, thereby being effective in the treatment of gout. Further, the present invention relates to a composition for the prevention of inflammation in gout, comprising an Angelica gigas Nakai extract which has an inhibitory effect on the inflammation-inducing enzyme Cox-2. The Angelica gigas Nakai extract of the present invention is a liquid concentrate consisting of 98% by weight or more of decursin and decursinol angelate as main ingredients, and for administration to human, it is extracted with water and ethanol only as an extraction solvent. In addition, a purification method using a difference in temperature and solubility is used, in order to increase its purity.

Abstract: A phase change material layer includes antimony (Sb) and at least one of indium (In) and gallium (Ga). A phase change memory device includes a storage node including a phase change material layer and a switching device connected to the storage node. The phase change material layer includes Sb and at least one of In and Ga.

Abstract: Provided is a baby formula maker including: a body for accommodating a water container and a powered formula container; a heater installed in the body and for heating water contained in the water container; a cooler including a radiator for cooling the heated water by receiving the heated water from the heater, a heat sink combined with the radiator to cool down the radiator, and a cooling fan for increasing cooling efficiency of the heat sink; and an operator for controlling operations of the heater according to a temperature of the water contained in the water container. Accordingly, the baby formula maker provides speed and convenience since a baby formula is promptly made by remarkably reducing a baby formula making time. Moreover, the baby formula maker has a sanitary, compact, and simple structure, and is economical since it is mass-productible.

Abstract: A method of forming a phase change layer using a Ge compound and a method of manufacturing a phase change memory device using the same are provided. The method of manufacturing a phase change memory device included supplying a first precursor on a lower layer on which the phase change layer is to be formed, wherein the first precursor is a bivalent precursor including germanium (Ge) and having a cyclic structure. The first precursor may be a cyclic germylenes Ge-based compound or a macrocyclic germylenes Ge-based, having a Ge—N bond. The phase change layer may be formed using a MOCVD method, cyclic-CVD method or an ALD method. The composition of the phase change layer may be controlled by a deposition pressure in a range of 0.001 torr-10 torr, a deposition temperature in a range of 150° C. to 350° C. and/or a flow rate of a reaction gas in the range of 0-1 slm.

Abstract: Provided are a method for removing and/or absorbing greenhouse gases using aquatic plant and/or algae having a greenhouse gas absorbing performance and resistance to toxic substances, a method for producing bioenergy using predators with high fatty acids, and a method for producing bioenergy including cultivating aquatic plant and/or algae having a greenhouse gas absorbing performance and resistance to toxic substances, while supplying a waste gas mixture to the aquatic plant and/or algae, (S2) cultivating predators having a capability to prey on the aquatic plant and/or algae while supplying the aquatic plant and/or algae to the predators, (S3) harvesting the predators, and (S4) converting the harvested predators into bioenergy.

Abstract: To provide a microorganism or a plant transformed with a ?-ionone ring-4-ketolase gene and/or ?-ionone ring-3-hydroxylase gene derived from Brevundimonas sp. strain SD-212. The ?-ionone ring-4-ketolase gene and ?-ionone ring-3-hydroxylase gene produced by Brevundimonas sp. strain SD-212 each have a high activity compared with those of known enzymes, and therefore microorganisms transformed with the genes encoding these enzymes can efficiently produce astaxanthin.

Abstract: Provided are a phase change layer and a method of forming the phase change layer and a phase change memory device including the phase change layer, and methods of manufacturing and operating the phase change memory device. The phase change layer may be formed of a quaternary compound including an amount of indium (In) ranging from about 15 at. % to about 20 at. %. The phase change layer may be InaGebSbcTed, wherein an amount of germanium (Ge) ranges from about 10 at. %?b?about 15 at. %, an amount of antimony (Sb) ranges from about 20 at. %?c?about 25 at. %, and an amount of tellurium (Te) ranges from about 40 at. %?d?about 55 at. %.

Abstract: Disclosed may be a phase change material alloy, a phase change memory device including the same, and methods of manufacturing and operating the phase change memory device. The phase change material alloy may include Si and Sb. The alloy may be a Si—O—Sb alloy further including O. The Si—O—Sb alloy may be SixOySbz, wherein, when x/(x+z) may be x1, 0.05?x1?0.30, 0.00?y?0.50, and x+y+z may be 1. The Si—O—Sb alloy may further comprise an element other than Si, O, and Sb.

Abstract: A method of forming a phase change layer may include providing a bivalent first precursor having germanium (Ge), a second precursor having antimony (Sb), and a third precursor having tellurium (Te) onto a surface on which the phase change layer is to be formed. The phase change layer may be formed by CVD (e.g., MOCVD, cyclic-CVD) or ALD. The composition of the phase change layer may be varied by modifying the deposition pressure, deposition temperature, and/or supply rate of reaction gas. The deposition pressure may range from about 0.001-10 torr, the deposition temperature may range from about 150-350° C., and the supply rate of the reaction gas may range from about 0-1 slm. Additionally, the above phase change layer may be provided in a via hole and bounded by top and bottom electrodes to form a storage node.

Abstract: A baby formula maker including: a main body in which a water tub and a baby formula tub are installed; a heating portion installed in the main body and heating water contained in the water tub; a time controller controlling time at which the water is heated by the heating portion; a cooling portion including a radiator cooling the water heated by the heating portion and one or a plurality of Peltier cooling modules attached to the radiator so as to lower the temperature of the radiator; and a electric current controller controlling temperatures of the one or the plurality of Peltier cooling modules. The time required to make milk for nursing can be remarkably reduced, and if milk for nursing is needed, immediate nursing can be carried out, and speed and convenience can be provided to the user, and the baby formula maker is sanitary and compact and has a simple structure and thus can be economically manufactured on a mass scale.

Abstract: Provided are a phase change layer and a method of forming the phase change layer and a phase change memory device including the phase change layer, and methods of manufacturing and operating the phase change memory device. The phase change layer may be formed of a quaternary compound including an amount of indium (In) ranging from about 15 at. % to about 20 at. %. The phase change layer may be InaGebSbcTed, wherein an amount of germanium (Ge) ranges from about 10 at. %?b?about 15 at. %, an amount of antimony (Sb) ranges from about 20 at. %?c?about 25 at. %, and an amount of tellurium (Te) ranges from about 40 at. %?d?about 55 at. %.

Abstract: Provided are a phase change layer and a method of forming the phase change layer and a phase change memory device including the phase change layer, and methods of manufacturing and operating the phase change memory device. The phase change layer may be formed of a quaternary compound including an amount of indium (In) ranging from about 15 at. % to about 20 at. %. The phase change layer may be InaGebSbcTed, wherein an amount of germanium (Ge) ranges from about 10 at. %?b?about 15 at. %, an amount of antimony (Sb) ranges from about 20 at. %?c?about 25 at. %, and an amount of tellurium (Te) ranges from about 40 at. %?d?about 55 at. %.

Abstract: A high-pressure liquefied extract of marine algae for producing bioethanol and a method of producing the liquid extract from marine algae under high pressure, and a method of producing the bioethanol from the high-pressure liquid extract by fermentation with yeast are disclosed. According to the production method of bioethanol using marine algae, the high-pressure liquefied extract can be obtained in high yield and fermentation time can be also reduced. Consequently, the yield of bioethanol is increased. Furthermore, the method gives economical and environmentally friendly values from natural marine algae.